$6 million Alzheimer grant announced

June 4, 2007

The U.S. National Institutes of Health has awarded a $6 million grant for the continuation of a promising study into Alzheimer's disease treatments.

The grant was awarded University of Missouri-Columbia biochemistry Professors Grace Sun and Gary Weisman, who are entering the second phase of a project aimed at identifying the causes of Alzheimer's disease.

As many as 20 million people worldwide are affected by Alzheimer's disease, with those numbers likely to triple by 2050 as the population ages.

"In the past five years, we have started to understand how this disease works," Sun said. "With the new grant, we will be able to go forward and see if there are treatments that can modify the cellular response in the brain."

Findings from the research program have been published in the Journal of Neuroinflammation, the Journal of Neuroscience and the Journal of Biological Chemistry.

Copyright 2007 by United Press International

Explore further: Opinion: The revelation that Big Sugar manipulated heart disease research is not an outlier

Related Stories

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Preserving the power of antibiotics

October 6, 2016

Of the 10 million prescriptions for antibiotics that emergency department physicians in the U.S. write each year, many are prescribed for known viral infections such as acute bronchitis and upper respiratory infections, which ...

Study questions rise of head and neck cancers in the UK

October 10, 2016

In the first study of its kind researchers from the University of Liverpool's Institute of Translational Medicine have examined the possible reasons for the rapid increase in incidence of particular head and neck cancers ...

Recommended for you

Fatty liver: Turning off TAZ reverses disease

October 27, 2016

Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.